These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25859625)

  • 1. Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
    Protopopescu C; Raffi F; Spire B; Hardel L; Michelet C; Cheneau C; Le Moing V; Leport C; Carrieri MP;
    Antivir Ther; 2015; 20(7):763-72. PubMed ID: 25859625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
    Protopopescu C; Raffi F; Brunet-François C; Salmon D; Verdon R; Reboud P; Carrieri MP; Leport C; Spire B; Michel L;
    Antivir Ther; 2012; 17(6):1079-83. PubMed ID: 22544079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
    Hema MN; Ferry T; Dupon M; Cuzin L; Verdon R; Thiébaut R; Protopopescu C; Leport C; Raffi F; Le Moing V;
    PLoS One; 2016; 11(8):e0161594. PubMed ID: 27548257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome of HIV-infected patients after 5 years of antiretroviral therapy including a protease inhibitor: the Aproco/Copilote Cohort].
    Le Moing V; Chêne G; Spire B; Raffi F; Leport C;
    Presse Med; 2005 Jun; 34(10 Suppl):1S31-7. PubMed ID: 16025665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.
    Villes V; Spire B; Lewden C; Perronne C; Besnier JM; Garré M; Chêne G; Leport C; Carrieri MP; Le Moings V;
    Antivir Ther; 2007; 12(7):1067-74. PubMed ID: 18018765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.
    Ferry T; Raffi F; Collin-Filleul F; Dupon M; Dellamonica P; Waldner A; Strady C; Chêne G; Leport C; Moing VL;
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):407-15. PubMed ID: 19474755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE Cohort.
    Préau M; Laguette V; March L; Rabaud C; Hardel L; Protopopescu C; Granier P; Pierret J; Leport C; Raffi F;
    AIDS Behav; 2017 Jan; 21(1):118-128. PubMed ID: 26910336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.
    Lewden C; Raffi F; Cuzin L; Cailleton V; Vildé JL; Chêne G; Allavena C; Salamon R; Leport C
    J Infect Dis; 2002 Sep; 186(5):710-4. PubMed ID: 12195361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
    Préau M; Protopopescu C; Raffi F; Rey D; Chêne G; Marcellin F; Perronne C; Ragnaud JM; Leport C; Spire B;
    AIDS Care; 2012; 24(4):434-43. PubMed ID: 21999644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.
    Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M
    Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
    Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort].
    Brunet-François C; Taieb A; Masquelier B; Le Moing V; Lewden C; Dellamonica P; Cuzin L; Allavena C; Spire B; Chêne G; Raffi F;
    Med Mal Infect; 2007 Mar; 37(3):172-7. PubMed ID: 17239554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evolution and determinants of renal function in HIV-infected patients who began receiving combination antiretroviral therapy in 1997-1999, ANRS CO8 APROCO-COPILOTE.
    Leport C; Bouteloup V; Rossert J; Garré M; Iordache L; Dellamonica P; Herson S; Raffi F; Chêne G
    Clin Infect Dis; 2009 Dec; 49(12):1950-4. PubMed ID: 19911986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
    Gutierrez F; Padilla S; Masiá M; Iribarren JA; Moreno S; Viciana P; Muñoz L; Gómez Sirvent JL; Vidal F; López-Aldeguer J; Blanco JR; Leal M; Rodríguez-Arenas MA; Perez Hoyos S;
    PLoS One; 2006 Dec; 1(1):e89. PubMed ID: 17183720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
    Ingle SM; May MT; Gill MJ; Mugavero MJ; Lewden C; Abgrall S; Fätkenheuer G; Reiss P; Saag MS; Manzardo C; Grabar S; Bruyand M; Moore D; Mocroft A; Sterling TR; D'Arminio Monforte A; Hernando V; Teira R; Guest J; Cavassini M; Crane HM; Sterne JA;
    Clin Infect Dis; 2014 Jul; 59(2):287-97. PubMed ID: 24771333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.